Catriona Jamieson, MD, PhD, discusses treatment considerations for patients with myelofibrosis.
Catriona Jamieson, MD, PhD, University of California San Diego
Advertisement
Articles by Catriona Jamieson, MD, PhD, University of California San Diego
Catriona Jamieson, MD, PhD, discusses the importance of treating patients with myelofibrosis at diagnosis.
Catriona Jamieson, MD, PhD, discusses symptom management in patients with myelofibrosis.
Advertisement
Latest Updated Articles
Rapid Readouts: Phase 2 Study of Navitoclax in High-Risk MyelofibrosisPublished: January 15th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5